Access WallStreet

Merck’s Recarbrio Gets FDA Priority Review for New Indication

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pfizer Inc. (PFE): Free Stock Analysis Report
 
Merck & Co., Inc. (MRK): Free Stock Analysis Report
 
Roche Holding AG (RHHBY): Free Stock Analysis Report
 
Sanofi (SNY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

< Access WallStreet home

RssEmailTwitterFacebook

Enter your email address to get our headlines in your email!

Delivered by FeedBurner

  • Nothing to display ...
Copyright 1999-2019 Access-WallStreet.com